CEO Interview: Brei...
Health Care: Drugs
Amicus Therapeutics Inc. (FOLD: NASDAQ)
$3.58 0.12 | 3.61%
05/22/13 - 11:38 AM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -48.78M | -44.41M | -54.94M | -6.57M |
| Operating Gains/Losses | 28.00K | 0.00 | 121.00K | 195.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 1.82M | -5.04M | 0.00 | 0.00 |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -863.00K | 1.42M | -1.34M | 839.00K |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | 3.18M | -5.22M | 32.50M | -47.96M |
| Other Non-Cash Items | 5.54M | 5.92M | 7.60M | 7.79M |
| Net Cash From Continuing Operations | -33.74M | -49.42M | -13.98M | -43.37M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -33.74M | -49.42M | -13.98M | -43.37M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 83.35M | 98.47M | 94.60M | 131.85M |
| Purchases of Property, Plant & Equipment | -4.32M | -1.42M | -384.00K | -1.81M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -118.46M | -50.60M | -113.66M | -98.17M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -39.43M | 46.45M | -19.44M | 31.87M |
| Issuance of Debt | 995.00K | 0.00 | 0.00 | 3.76M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 81.82M | 359.00K | 45.22M | 60.00K |
| Repayment of Long-Term Debt | -1.34M | -1.29M | -1.56M | -1.05M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 81.48M | -934.00K | 43.66M | 2.77M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 8.30M | -3.90M | 10.23M | -8.73M |
Portfolios with FOLD
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserWatchlist
- ContributorStocks With Big Insider Buy...
- Contributor22 Biopharma Stocks With Br...
Latest FOLD Headlines from TheStreet
- Amicus Therapeutics To Present At UBS Global Healthcare Conference 05.14.13 | 10:05 am
- Amicus Therapeutics Announces First Quarter 2013 Financial Results And Corporate Updates 05.09.13 | 04:05 pm
- Amicus Therapeutics To Announce First Quarter 2013 Financial Results On May 9, 2013 05.02.13 | 12:05 pm
- Amicus Therapeutics To Present At 12th Annual Needham Healthcare Conference 04.24.13 | 10:04 am
- Amicus Therapeutics Announces Full-Year 2012 Financial Results And Corporate Updates 03.12.13 | 04:03 pm
- Amicus Therapeutics To Announce Full-Year 2012 Financial Results On March 12, 2013 03.07.13 | 07:03 am
- Amicus Therapeutics Introduces Proprietary "CHART" Platform Technology 03.04.13 | 07:03 am
- Amicus Therapeutics To Present At Cowen And Company 33rd Annual Health Care Conference 02.27.13 | 04:02 pm
- A Legit Reason To Give Amicus' Fabry Drug Another Chance 02.19.13 | 06:02 am
- Amicus Therapeutics Presents Additional 6-Month Results From Phase 3 Fabry Monotherapy Study At LDN World Symposium 02.15.13 | 10:02 am
Press Releases for FOLD
- Amicus Therapeutics Joins Russell 3000® Index - PR Newswire 06.27.11 | 09:06 am
- Amicus Therapeutics To Present At Jefferies 2011 Global Healthcare Conference On Tuesday, June 7, 2011 - PR Newswire 05.31.11 | 09:05 am
- Amicus Therapeutics Announces Transition Of John F. Crowley From Chairman And Chief Executive Officer To Executive Chairman - PR Newswire 04.18.11 | 04:04 pm
- Amicus Therapeutics To Present At The 13th Annual BIO CEO And Investor Conference On Tuesday, February 15, 2011 - PR Newswire 02.10.11 | 08:02 am
- Amicus Therapeutics Initiates Phase 2 Clinical Trial Evaluating Amigal⢠Co-administered With Enzyme Replacement Therapy - PR Newswire 02.09.11 | 07:02 am
- Amicus Therapeutics To Host Its Third Quarter 2010 Financial Results Conference Call And Webcast On November 8, 2010 - PR Newswire 11.02.10 | 08:11 am
- Amicus Therapeutics To Host Conference Call And Webcast To Discuss Exclusive Worldwide Agreement With GSK To Develop And Commercialize Amigal⢠For Fabry Disease - PR Newswire 10.29.10 | 06:10 am
- Amicus Therapeutics To Present At The BIO Investor Forum On October 5, 2010 - PR Newswire 09.30.10 | 08:09 am
- Amicus Therapeutics To Present At The Canaccord Genuity 30th Annual Growth Conference On August 12, 2010 - PR Newswire 08.04.10 | 08:08 am
- Amicus Therapeutics To Host Its Second Quarter 2010 Financial Results Conference Call And Webcast On August 5, 2010 - PR Newswire 07.27.10 | 08:07 am
Partner Headlines for FOLD
- Curing Parkinson's: The Alternative Approach - Is There Money To Be Made? - Seeking Alpha 04.04.13 | 09:04 am
- After-Hours Earnings Report for March 12, 2013 : KW, DOLE, ACAD, GCA, GNMK, AVID, WSR, KTOS, GERN, ACRX, FOLD, GCAP - NASDAQ 03.12.13 | 06:03 pm
- Mid-Week Biopharma Catalyst Trades To Consider - Seeking Alpha 12.13.12 | 09:12 am
- Glaxo Invests in Nigeria - Analyst Blog - Zacks 11.28.12 | 09:11 am
- 5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments - Seeking Alpha 10.09.12 | 09:10 am
- 3 Best Biotech Stocks For This Week (Part V) - Seeking Alpha 10.08.12 | 09:10 am
- Glaxo Aims to Expand Synflorix Label - Analyst Blog - NASDAQ 09.19.12 | 03:09 pm
- Glaxo Increases Stake in RGDX - Analyst Blog - NASDAQ 09.18.12 | 09:09 pm
- Glaxo to Increase Stake in Amicus - Analyst Blog - Zacks 07.19.12 | 06:07 pm
- Healthcare Business Review: Somaxon Goes WILD, Amicus's Great DEAL - Wall St. Cheat Sheet 07.19.12 | 08:07 am
